MAP2K7 and melanoma: Recent reports showed that there was a poor correlation between phospho-ERK inhibition and the anti-proliferative effects of MEK inhibitors in melanoma cells, showing that Ki67, DUSP, Sprouty and phospho-MEK were possible markers for effects of MEK inhibitors [20], [28].